LN-3118

N/A

Report date: 2025/01/26 18:12:11
NME

Base Information

Drug NameLN-3118
Drug Alias NameMKK4-inhibitor (Eberhard Karls Universitat Tubingen)LN-3118
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDual specificity mitogen-activated protein kinase kinase 4 inhibitors
TargetsDual specificity mitogen-activated protein kinase kinase 4
Therapy Area/IndicationsLiver CirrhosisFatty Liver
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEberhard Karls University Tübingen
China Registration ClassN/A

Develop Information

Active CompaniesEberhard Karls University Tübingen
Inactive CompaniesN/A
Active IndicationsLiver CirrhosisFatty Liver
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A